Navigation Links
New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
Date:5/5/2008

100% of Insulin Doses Administered Were Delivered Within Pre-Determined

Guidelines and Standard Dosing Limitations

BRIDGEWATER, N.J., May 5 /PRNewswire-FirstCall/ -- A new study examining the dose accuracy of the SoloSTAR(R) disposable insulin pen, prefilled with Lantus(R) (insulin glargine [rDNA origin] injection) or Apidra(R) (insulin glulisine [rDNA origin] injection), found the pens accurately delivered all insulin doses within standard limits defined by the International Organization for Standardization (ISO). Lantus(R) SoloSTAR(R) was approved by the U.S. Food and Drug Administration (FDA) on April 25, 2007. Apidra(R) for use in the SoloSTAR(R) prefilled disposable pen is currently under review at the FDA. The study, presented on May 2, 2008 at the 43rd Congress of the German Society for Diabetes (DDG) in Munich, Germany, examined the accuracy of both pens at multiple target dosages to determine the proportion of doses that fell within ISO ranges.

"For people with diabetes who use an insulin pen to deliver their insulin, dose accuracy is essential for their treatment," stated Norbert Hermanns, Ph.D., director of the Research Institute of the Diabetes Academy Mergentheim, Bad Mergentheim, Germany, and lead investigator in the study. "Based on the findings of this study, we concluded that the SoloSTAR(R) pen is an accurate insulin delivery option for people with diabetes."

The study participants, a random sample of 60 hospital inpatients with type 1 and type 2 diabetes, were trained on correct use of the SoloSTAR(R) pen. Participants were then asked to inject three target doses with Lantus(R) into an insulin-sponge, in doses of 10 (low), 40 (medium) and 80 (high) units, and three doses of Apidra(R) in doses of 5 (low), 15 (medium) and 30 (high) units. The quantity of insulin delivered was calculated by the weight of the insulin pens before and after injection. The order of the dosages was randomized. All doses (100%)
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
4. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
5. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
6. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
7. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
8. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
9. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
10. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
11. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)...  Obsidian HDS, the developer of PharmaShine ( ... management of data on pharmaceutical and device industry payments ... the 2014 Open Payments General and Research data released ... The data disclosed on Open Payments for 2014 includes ... totaling $6.49 billion and is the largest public disclosure ...
(Date:7/2/2015)... VANCOUVER , July 2, 2015 /PRNewswire/ - ... today that its common shares have been approved for listing ... symbol "EPIX". ESSA will begin trading on NASDAQ ... on the TSX Venture Exchange under the symbol "EPI". ... shares on the NASDAQ, each of the Company,s outstanding special ...
(Date:7/2/2015)... , July 2, 2015 ... as ,Friendly Aedes aegypti , , reduced ... Brazil by 95%, well below ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal PLOS ... trial of Oxitec,s genetically engineered mosquitoes. The results showed ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
... YORK, Nov. 18, 2010 Reportlinker.com announces that ... its catalogue: Global Biosimilars (Follow-on ... http://www.reportlinker.com/p0330557/Global-Biosimilars-Follow-on-biologics-Market-An-Analysis.html Biosimilars or FOBs (Follow-on ... biological drugs, developed subsequent to the patent expiry ...
... consumers to age well with a unique new line ... leading global specialty retailer of nutritional products is launching ... complete line of nutritional supplements designed to help you ... support health and bioavailability enhancement technology to improve the ...
Cached Medicine Technology:Reportlinker Adds Global Biosimilars (Follow-on biologics) Market: An Analysis 2Reportlinker Adds Global Biosimilars (Follow-on biologics) Market: An Analysis 3Reportlinker Adds Global Biosimilars (Follow-on biologics) Market: An Analysis 4GNC Empowers Consumers to Age Well With Exclusive New Line Designed to Proactively Influence Health Destiny 2GNC Empowers Consumers to Age Well With Exclusive New Line Designed to Proactively Influence Health Destiny 3GNC Empowers Consumers to Age Well With Exclusive New Line Designed to Proactively Influence Health Destiny 4
(Date:7/3/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and expose popular lies regarding proper relationships according to the bible. , ... the core of the subject by explaining why certain types of sexual relationships are ...
(Date:7/2/2015)... ... 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... Star State. The premium frozen yogurt chain was listed as #22 on the Inc. 500 ... the Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... structure retrofit project at the University of Minnesota, they knew it would save ... would also be an award-winning choice: the total energy savings after installation was ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was ... and coolest technology products available to consumers. Amanda Forstrom, a technology expert and special ... are the most versatile smart light bulbs on the market. , According to the ...
(Date:7/2/2015)... ... July 02, 2015 , ... Six months ahead of ... cross-country walk to raise awareness and money for the Pulmonary Hypertension Association (PHA). ... at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday morning ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... Recent findings by Dutch researchers suggest that the hormone ... thought to be//. The steroid is prescribed by many ... ,The steroid hormones called glucocorticoids are employed ... thought to influence the body’s immune responses in a ...
... A medical college counsellor set afire by his patient ... Chandra Bose Medical College hospital// in Jabalpur where the ... counsellor, Sanjay Shrivastava suffered 80 percent burns when he ... Sidhi district. The counsellor had refused to advise Jaiswal ...
... Leafy greens and beans aren't the only foods that ... a healthy// start to pregnancy. ,Researchers now ... with a full day's worth of the nutrient in ... this week's online edition of the journal PNAS, Proceedings ...
... genetic and geographic data of the H5N1 avian flu ... //They found that multiple strains of the virus originated ... many of the migration routes through which the strains ... H5N1 strains develop and migrate, health officials can better ...
... cells form by hijacking a developmental genetic process normally ... Institute of Technology and the Ovarian Cancer Institute discovered ... of fallopian tubes and is present in ovarian cancer ... not only provides a new target for diagnostic and ...
... that may make people even more wary of using agricultural ... common chemical weed killer could be the hidden hand behind ... with certain genes that render them susceptible to one of ... study published in the Journal of Neuroscience, the researchers from ...
Cached Medicine News:Health News:Scientists Genetically Engineer Tomatoes With Enhanced Folate Content 2Health News:UCI Scientists Reconstruct Migration of Avian Flu Virus 2Health News:Ovarian Cancer May Mimic Fallopian Tube Formation 2Health News:Ovarian Cancer May Mimic Fallopian Tube Formation 3Health News:Weed Killer Plays a Pivotal Role in Those With Genetic Vulnerability to Parkinson’ 2
... Combines BchiVac V-500 with Vacuum Controller ... controls vacuum levels from Model ... designed to handle most vacuum applications. Applications ... to two rotary evaporators Laboratory vacuum ...
... water-cooled secondary condenser to trap residual solvent ... a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with ... Laboratory vacuum source for instruments including vacuum ...
... Universal Vacuum System UVS400A is a multi-tasking ... UVS400A combines a refrigerated vapor trap and ... single integrated unit. The easy-to-use, wide-mouth glass ... into single jar for easy disposal. The ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
Medicine Products: